Get started

TECH

ATOS: Selling rallies as lower prices are expectedATOS - Intraday - We look to Sell at 38.73 (stop at 41.72) The medium term bias remains bearish. Trading within a Bearish Channel formation. A move lower has resulted in prices breaking from the previous range and confirmed our bearish expectation. The formation has a measured move target of 30.61. Further downside is expected although we prefer to set shorts at our bespoke resistance levels at 38.73, resulting in improved risk/reward. Our profit targets will be 30.60 and 28.00 Resistance: 38.74 / 41.13 / 47.16 Support: 36.40 / 36.00 / 34.62 Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features. Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
EURONEXT:ATOShort
by Saxo
Xiaomi bottomed - We are heading towards new All-time highs!Hey Investor, please see my current idea on the Xiaomi stock, where my count suggests a possible bottom for a trend reversal in order to make new highs. This is calculated based on my Elliot Waves Count by the fact, that wave C has the same length as wave a. I have checked the inner structure of wave C in order to check the inner structure of this wave. Based on this knowledge I am very confident that we might have our bottom here. Let me know what you think. This is no financial advice, just my technical view. RT
HKEX:1810
by RT_Trading_
1
$NDQ #QQQ $QQQ pulling a Wu-Tang patternlooking at the 1hr chart, there is a classic W pattern formation going on here. December was a tough month for tech, and looks to be finally recovering. This weeks moves show a break above the prior down channel, with tightly wound consolidation. TBH I see this going in either direction, but with the tax loss harvesting done for 2021, my money is on volume buy-ins this month, with a beginning of a reversal in March when tapering is ending and rates are set to go up. NFA
TVC:NDQ
by corgicapitalllc
Hello Group lost big support levelThis stock has been slashed over this year. It has lost an important support level and it's following the same trend as other companies such as Robinhood, Bumble, Victoria's Secret, Vimeo or Deliveroo + the Chinese Crisis. We expect someday a trend reversal, so for now we recommend to place price alerts. Key level, the weekly resistance line (at $12 per share - a good one for selling-short). Moreover, it's not a bad entry for swing traders with stop loss on last lows, as a bullish divergence on the daily chart is almost complete.
NASDAQ:MOMO
by alvaromroo
1
Novacyt ALNOV Graham Mullis, CEO of the Novacyt Group, commented: “Novacyt continues to process COVID-19 tests for current and future demand. We continue to ensure that innovation is at the center of our strategy and that our growing portfolio of COVID-19 tests is available to clients in private and public healthcare facilities to expand existing partnerships and support new partnerships. Throughout the pandemic, the demand for NHS testing has remained a key priority for the company and the award of the contract under the National PHE Microbiology Framework is a testament to our continued commitment. “We believe that our long-term strategy also supports the growth of Novacyt after COVID-19. In particular, our progress and growth potential in the private sector will not only help us maximize the opportunity for COVID-19 testing, but also ensure that we are well positioned, along with technologies and partners, for sustainable growth. beyond COVID-19. We therefore believe that Novacyt is well placed to continue to develop its business transformation. " This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014. About the Novacyt Group The Novacyt Group is an international diagnostic company generating a growing portfolio of in vitro and molecular diagnostic tests. Its main strengths lie in the development, marketing, design and manufacture of diagnostic products. The main business units of the Company include the Primerdesign and Lab21 products, providing a wide range of high quality assays and reagents worldwide. The Group directly serves the microbiology, hematology and serology markets as well as its global partners, including large companies.
EURONEXT:ALNOVLong
by wallstreetstocks